CCDC85B promotes non-small cell lung cancer cell proliferation and invasion

CCDC85B promotes non-small cell lung cancer cell proliferation and invasion
复制标题

DOI:
10.1002/mc.22914
复制
发表时间:
2019-01-01
影响因子:
4.6
通讯作者:
Wang, Enhua
Wang, Enhua
中科院分区:
医学2区
文献类型:
--
作者:
Feng, Yangyang;Gao, Yue;Wang, Enhua

文献摘要

被引文献

相似文献

含有85B的线圈结构域(CCDC85B)参与多种生物过程;然而,其在人类癌症中的表达模式和功能尚不清楚。本研究发现,CCDC85B在非小细胞肺癌(NSCLC)肿瘤细胞细胞质中的表达明显高于邻近正常肺组织(P < 0.05)。此外,CCDC85B表达与NSCLC TNM晚期(P = 0.004)和区域淋巴结转移阳性(P = 0.009)相关。此外,在A549和H1299肺癌细胞系中,CCDC85B过表达促进细胞增殖和侵袭,而sirna介导的CCDC85B敲低则表现出相反的作用。CCDC85B促进AKT和GSK3 β磷酸化,上调活性β -连环蛋白、Wnt靶点c-myc、cyclin D1和MMP7的水平。此外,在pi3k抑制剂LY294002治疗后,ccdc85b诱导的磷酸化GSK3 β和活性β -连环蛋白上调得以恢复。综上所述,CCDC85B通过激活AKT/GSK3 β / β -catenin致癌信号通路促进肺癌细胞的增殖和侵袭,与NSCLC进展相关。因此,CCDC85B可能成为NSCLC治疗的新靶点。
Coiled-coil domain containing 85 B (CCDC85B) is involved in diverse biological processes; however, its expression patterns and functions in human cancers are yet unknown. The present study demonstrated that the expression of CCDC85B in the cytoplasm of the non-small cell lung cancer (NSCLC) tumor cells was significantly higher compared to adjacent normal lung tissues (P < 0.05). Furthermore, CCDC85B expression correlated with advanced TNM stage (P = 0.004) and positive regional lymph node metastasis (P = 0.009) of NSCLC. In addition, in A549 and H1299 lung cancer cell lines, the overexpression of CCDC85B promoted cell proliferation and invasion, while siRNA-mediated CCDC85B knockdown exhibited opposite effects. CCDC85B promoted AKT and GSK3 beta phosphorylation and upregulated the levels of active beta-catenin, Wnt targets c-myc, cyclin D1, and MMP7. Besides, the CCDC85B-induced upregulation of phosphorylated GSK3 beta and active beta-catenin was rescued following the treatment with PI3 K inhibitor, LY294002. In conclusion, CCDC85B was associated with NSCLC progression as it promoted the proliferation and invasion of lung cancer cells through activated AKT/GSK3 beta/beta-catenin oncogenic signaling pathway. Therefore, CCDC85B might serve as a novel target for NSCLC treatment.